Table of Contents
Chapter 1 Executive Summary
Chapter 2 Market Snapshot
Chapter 3 Market Variables, Trends & Scope
3.1 Market segmentation& scope
3.1.1 Market Driver Analysis
3.1.1.1. Growing drug development industry
3.1.1.2 Advancements in computer technology
3.1.1.3 Increasing prevalence of chronic diseases
3.1.2 Market Restraint Analysis
3.2 Penetration & growth prospect mapping
3.3 Chemoinformatics - SWOT Analysis, By Factor (political & legal, economic and technological)
3.4 Industry Analysis - Porter’s
Chapter 4 Market Categorization 1: Applications Estimates & Trend Analysis
4.1 Chemoinformatics market: Application movement analysis
4.2 Chemical Analysis
4.2.1 Chemical analysis market estimates and forecasts, 2013 - 2024 (USD Million)
4.2.2 Chemical Databases
4.2.3 Chemometrics
4.2.4 Molecular Modelling
4.2.5 Computer-Assisted Structure Elucidation
4.2.6 Computer-Assisted Synthesis Design
4.3 Drug Discovery
4.3.1 Drug discovery market estimates and forecasts, 2013 - 2024 (USD Million)
4.3.2 High Throughput Screening
4.3.3 Lead Identification and Optimization
4.3.4 QSAR/QSPR
4.3.5 ADME-Toxicology Prediction
4.4 Drug Validation
4.4.1 Drug Validation market estimates and forecasts, 2013 - 2024 (USD Million)
4.5 Others
4.5.1 Others market estimates and forecasts, 2013 - 2024 (USD Million)
Chapter 5 Market Categorization 3: Regional Estimates & Trend Analysis, by Product & Application
5.1 Chemoinformatics market share by region, 2014 & 2024
5.2 North America
5.2.1 North America chemoinformatics market estimates and forecasts, 2013 - 2024 (USD Million)
5.2.2 U.S.
5.2.2.1 U.S. chemoinformatics market estimates and forecasts, 2013 - 2024 (USD Million)
5.2.3 Canada
5.2.3.1 Canada chemoinformatics market estimates and forecasts, 2013 - 2024 (USD Million)
5.3 Europe
5.3.1 Europe chemoinformatics market estimates and forecasts, 2013 - 2024 (USD Million)
5.3.2 Germany
5.3.2.1 Germany chemoinformatics market estimates and forecasts, 2013 - 2024 (USD Million)
5.3.3 UK
5.3.3.1 UK chemoinformatics market estimates and forecasts, 2013 - 2024 (USD Million)
5.4 Asia Pacific
5.4.1 Asia Pacific chemoinformatics market estimates and forecasts, 2013 - 2024 (USD Million)
5.4.2 Japan
5.4.2.1 Japan chemoinformatics market estimates and forecasts, 2013 - 2024 (USD Million)
5.4.3 China
5.4.3.1 China chemoinformatics market estimates and forecasts, 2013 - 2024 (USD Million)
5.4.4 India
5.4.4.1 India chemoinformatics market estimates and forecasts, 2013 - 2024 (USD Million)
5.5 Latin America
5.5.1 Latin America chemoinformatics market estimates and forecasts, 2013 - 2024 (USD Million)
5.5.2 Brazil
5.5.2.1 Brazil chemoinformatics estimates and forecasts, 2013 - 2024 (USD Million)
5.5.3 Mexico
5.5.3.1 Mexico chemoinformatics market estimates and forecasts, 2013 - 2024 (USD Million)
5.6 Middle East And Africa
5.6.1 Middle East and Africa chemoinformatics market estimates and forecasts, 2013 - 2024 (USD Million)
5.6.2 South Africa
5.6.2.1 South Africa chemoinformatics market estimates and forecasts, 2013 - 2024 (USD Million)
Chapter 6 Competitive Landscape
6.1 Strategy framework
6.2 Market participation categorization
6.3 Company Profiles
6.3.1 BIOVIA (Accelrys)
6.3.1.1 Company Overview
6.3.1.2 Financial Performance
6.3.1.3 Product Benchmarking
6.3.1.4 Strategic Initiatives
6.3.2 Agilent Technologies, Inc.
6.3.2.1 Company Overview
6.3.2.2 Financial Performance
6.3.2.3 Product Benchmarking
6.3.2.4 Strategic Initiatives
6.3.3 Bio-Rad Laboratories, Inc.
6.3.3.1 Company Overview
6.3.3.2 Financial Performance
6.3.3.3 Product Benchmarking
6.3.3.4 Strategic Initiatives
6.3.4 BioSolveIT GmbH
6.3.4.1 Company Overview
6.3.4.2 Financial Performance
6.3.4.3 Product Benchmarking
6.3.4.4 Strategic Initiatives
6.3.5 Schrödinger, Inc.
6.3.5.1 Company Overview
6.3.5.2 Financial Performance
6.3.5.3 Product Benchmarking
6.3.5.4 Strategic Initiatives
6.3.6 Molecular Discovery Ltd.
6.3.6.1 Company Overview
6.3.6.2 Financial Performance
6.3.6.3 Product Benchmarking
6.3.6.4 Strategic Initiatives
6.3.7 ChemAxon, Inc.
6.3.7.1 Company Overview
6.3.7.2 Financial Performance
6.3.7.3 Product Benchmarking
6.3.7.4 Strategic Initiatives
6.3.8 Jubilant Biosys, Inc.
6.3.8.1 Company Overview
6.3.8.2 Financial Performance
6.3.8.3 Product Benchmarking
6.3.8.4 Strategic Initiatives
6.3.9 Cerep, Inc.
6.3.9.1 Company Overview
6.3.9.2 Financial Performance
6.3.9.3 Product Benchmarking
6.3.9.4 Strategic Initiatives
6.3.10 OpenEye Scientific Software, Inc.
6.3.10.1 Company Overview
6.3.10.2 Financial Performance
6.3.10.3 Product Benchmarking
6.3.10.4 Strategic Initiatives
List of Tables
TABLE 1 North America chemoinformatics market, by application, 2013 - 2024 (USD Million)
TABLE 2 U.S. chemoinformatics market, by application, 2013 - 2024 (USD Million)
TABLE 3 Canada chemoinformatics market, by application, 2013 - 2024 (USD Million)
TABLE 4 Europe chemoinformatics market, by application, 2013 - 2024 (USD Million)
TABLE 5 Germany chemoinformatics market, by application, 2013 - 2024 (USD Million)
TABLE 6 UK chemoinformatics market, by application, 2013 - 2024 (USD Million)
TABLE 7 Asia Pacific chemoinformatics market, by application, 2013 - 2024 (USD Million)
TABLE 8 Japan chemoinformatics market, by application, 2013 - 2024 (USD Million)
TABLE 9 China chemoinformatics market, by application, 2013 - 2024 (USD Million)
TABLE 10 India chemoinformatics market, by application, 2013 - 2024 (USD Million)
TABLE 11 Latin America chemoinformatics market, by application, 2013 - 2024 (USD Million)
TABLE 12 Brazil chemoinformatics market, by product, 2013 - 2024 (USD Million)
TABLE 13 Mexico chemoinformatics market, by application, 2013 - 2024 (USD Million)
TABLE 14 Middle East and Africa chemoinformatics market, by application, 2013 - 2024 (USD Million)
TABLE 15 South Africa chemoinformatics market, by application, 2013 - 2024 (USD Million)
List of Figures
FIG. 1 Market summary
FIG. 2 Market trends & outlook
FIG. 3 Market segmentation & scope
FIG. 4 Market driver relevance analysis (Current & future impact)
FIG. 5 Market restraint relevance analysis (Current & future impact)
FIG. 6 Penetration & growth prospect mapping
FIG. 7 SWOT Analysis, By Factor (political & legal, economic and technological)
FIG. 8 Porter’s Five Forces Analysis
FIG. 9 Chemoinformatics market: Application movement analysis
FIG. 10 Global chemical analysis market estimates and forecasts, 2013 - 2024 (USD Million)
FIG. 11 Global drug discovery analysis market estimates and forecasts, 2013 - 2024 (USD Million)
FIG. 12 Global drug validation market estimates and forecasts, 2013 - 2024 (USD Million)
FIG. 13 Global other applications market estimates and forecasts, 2013 - 2024 (USD Million)
FIG. 14 Regional market place: Key takeaways
FIG. 15 Regional outlook, 2015 & 2024
FIG. 16 North America chemoinformatics market estimates and forecasts, 2013 - 2024 (USD Million)
FIG. 17 U.S. chemoinformatics market estimates and forecasts, 2013 - 2024 (USD Million)
FIG. 18 Canada chemoinformatics market estimates and forecasts, 2013 - 2024 (USD Million)
FIG. 19 Europe chemoinformatics market estimates and forecasts, 2013 - 2024 (USD Million)
FIG. 20 Germany chemoinformatics market estimates and forecasts, 2013 - 2024 (USD Million)
FIG. 21 UK chemoinformatics market estimates and forecasts, 2013 - 2024 (USD Million)
FIG. 22 Asia Pacific chemoinformatics market estimates and forecasts, 2013 - 2024 (USD Million)
FIG. 23 Japan chemoinformatics market estimates and forecasts, 2013 - 2024 (USD Million)
FIG. 24 China chemoinformatics market estimates, by application, 2013 - 2015 (USD Million)
FIG. 25 India chemoinformatics market estimates and forecasts, 2013 - 2024 (USD Million)
FIG. 26 Latin America chemoinformatics market estimates and forecasts, 2013 - 2024 (USD Million)
FIG. 27 Brazil chemoinformatics market estimates and forecasts, 2013 - 2024 (USD Million)
FIG. 28 Mexico chemoinformatics market estimates, by product, 2013 - 2015 (USD Million)
FIG. 29 Middle East and Africa chemoinformatics market estimates and forecasts, 2013 - 2024 (USD Million)
FIG. 30 South Africa chemoinformatics market estimates and forecasts, 2013 - 2024 (USD Million)
FIG. 31 Strategy framework
FIG. 32 Participant categorization